Volume 20 No 22 (2022)
 Download PDF
Long term PPI (Proton Pump Inhibitor) use in patients with Diabetes: Review article
Monalisa Khuntia, Prof. Susant Mishra, Sanjay Chan, Prof. Abhay Sahoo, Dr. Santosh Kumar Swain, Dr. Hariballav Mahapatra
This review article analyses the existing research on the prolonged use of proton pump inhibitors (PPIs) to diabetic patients. The article summarises the findings of previous studies that have examined the effects of PPIs on glycemic control, cardiovascular outcomes, and other complications associated with diabetes. The review also evaluates the advantages and drawbacks of long-term PPI apply in this patient population. Overall, the evidence suggests that there is no clear consensus regarding the effect of PPIs on glycemic control, cardiovascular outcomes, or other diabetic complications. While some studies suggests persistent PPI usage may be connected with improved glycemic control and reduced cardiovascular risk, these results are not consistent. Additional research is required to further evaluate the potential advantages and hazards of PPI usage in individuals with diabetes.
Proton Pump Inhibitors, Diabetes, Glycemic Control, Cardiovascular Outcomes, Complications
Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.